Anthem Biosciences Limited (BOM:544449)
India · Delayed Price · Currency is INR 607.45
+13.80 (2.32%)
At close: Jan 22, 2026
Anthem Biosciences Revenue
Anthem Biosciences had revenue of 5.50B INR in the quarter ending September 30, 2025, with 4.78% growth. This brings the company's revenue in the last twelve months to 20.77B, up 22.34% year-over-year. In the fiscal year ending March 31, 2025, Anthem Biosciences had annual revenue of 18.50B with 30.29% growth.
Revenue (ttm)
20.77B
Revenue Growth
+22.34%
P/S Ratio
16.46
Revenue / Employee
10.58M
Employees
1,825
Market Cap
341.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 18.50B | 4.30B | 30.29% |
| Mar 31, 2024 | 14.20B | 3.62B | 34.24% |
| Mar 31, 2023 | 10.58B | -1.83B | -14.74% |
| Mar 31, 2022 | 12.41B | 1.35B | 12.24% |
| Mar 31, 2021 | 11.05B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Godrej Industries | 225.81B |
| NLC India | 162.51B |
| Blue Star | 122.31B |
| United Breweries | 92.40B |
| Godfrey Phillips India | 59.37B |
| 3M India | 47.51B |
| Honeywell Automation India | 45.38B |
| J. B. Chemicals & Pharmaceuticals | 41.93B |